Table 3.
Variables | Chi-square | p-value | Cramer’s V | |
---|---|---|---|---|
Type of information | Sources | 243,70 | 0,000 ** | 0,71 |
Type of information | Content | 246,01 | 0,000 ** | 0,70 |
Tone | Discourse | 396,72 | 0,000 ** | 0,63 |
Type of information | User | 77,59 | 0,000 ** | 0,42 |
Type of information | Discourse | 49,72 | 0,000 ** | 0,32 |
Type of information | Disease | 13,33 | 0,001 ** | 0,16 |
Tone | Content | 55,76 | 0,009 ** | 0,13 |
User | Disease | 17,21 | 0,028 * | 0,13 |
Tone | User | 14,36 | 0,07 | 0,12 |
Tone | Type of information | 5,27 | 0,072 | 0,10 |
Tone | Pharmaceutical company | 4,26 | 0,119 | 0,09 |
Tone | Sources | 5,62 | 0,229 | 0,08 |
** denotes that the relationship is statistically significant with a level of confidence of 99 % (p-value < 0.01).
* denotes that the relationship is statistically significant with a level of confidence of 95 % (p-value < 0.05).